FDA approves belimumab autoinjector for pediatric systemic lupus erythematosus
The U.S. Food and Drug Administration has approved GlaxoSmithKline's 200-mg subcutaneous route of administration of Benlysta (belimumab) for patients 5 ...
Read moreDetails
